In particular, the naphthalene compound 5-amino-2-naphthalenesulfonate, has been reported to inhibit both FGF1 and FGF227, a property whose pro and cons are still debated in view of the redundancy and promiscuity of the FGF/FGFR system in cancer. The gene discussed is FGF1; the disease is cancer.